| Year |
Citation |
Score |
| 2010 |
Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, Zhu X, Smith MA. Novel therapeutics for Alzheimer's disease: an update. Current Opinion in Drug Discovery & Development. 13: 235-46. PMID 20205057 |
0.731 |
|
| 2009 |
Friedlich AL, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Lee HG, Casadesus G, Perry G, Smith MA. Treatment advances in Alzheimer's disease based on the oxidative stress model. F1000 Medicine Reports. 1. PMID 20948726 DOI: 10.3410/M1-54 |
0.59 |
|
| 2009 |
Yi J, Horky LL, Friedlich AL, Shi Y, Rogers JT, Huang X. L-arginine and Alzheimer's disease. International Journal of Clinical and Experimental Pathology. 2: 211-38. PMID 19079617 |
0.462 |
|
| 2009 |
Friedlich AL, Smith MA, Zhu X, Takeda A, Nunomura A, Moreira PI, Perry G. Oxidative Stress in Parkinson`s Disease The Open Pathology Journal. 3: 38-42. DOI: 10.2174/1874375700903010038 |
0.704 |
|
| 2005 |
Puglielli L, Friedlich AL, Setchell KD, Nagano S, Opazo C, Cherny RA, Barnham KJ, Wade JD, Melov S, Kovacs DM, Bush AI. Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. The Journal of Clinical Investigation. 115: 2556-63. PMID 16127459 DOI: 10.1172/Jci23610 |
0.359 |
|
| 2005 |
Friedlich AL, Bush AI. Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. 157-165. DOI: 10.1017/CBO9780511544873.014 |
0.395 |
|
| 2004 |
Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD, Koh JY, Bush AI. Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3453-9. PMID 15056725 DOI: 10.1523/Jneurosci.0297-04.2004 |
0.302 |
|
| 2001 |
Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiology of Disease. 8: 479-91. PMID 11447996 DOI: 10.1006/Nbdi.2001.0406 |
0.612 |
|
| 2001 |
Andreassen OA, Dedeoglu A, Friedlich A, Ferrante KL, Hughes D, Szabo C, Beal MF. Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Experimental Neurology. 168: 419-24. PMID 11259130 DOI: 10.1006/Exnr.2001.7633 |
0.493 |
|
| 2000 |
Friedlich AL, Beal MF. Prospects for redox-based therapy in neurodegenerative diseases. Neurotoxicity Research. 2: 229-37. PMID 16787843 DOI: 10.1007/Bf03033796 |
0.559 |
|
| 1999 |
Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport. 10: 2411-5. PMID 10439473 DOI: 10.1097/00001756-199908020-00035 |
0.695 |
|
| Show low-probability matches. |
